CervoMed to Participate in Fireside Chat to Highlight Recent Progress in the Neflamapimod Clinical Development Program at the Canaccord Genuity 46th Annual Growth Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| (NASDAQ: CRVO) | Delayed: 3.18 -0.16 (4.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.34 | 52 Week High | $ | |||
| Open | $3.26 | 52 Week Low | $ | |||
| Day High | $3.36 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $ | |||
| Volume | 309,462 | |||||
